M&T Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.84M | Sell |
13,088
-1,644
| -11% | -$767K | 0.02% | 359 |
|
|
2025
Q4 | $6.68M | Buy |
14,732
+2,408
| +20% | +$1.04M | 0.02% | 344 |
|
|
2025
Q3 | $4.83M | Sell |
12,324
-5,359
| -30% | -$2.24M | 0.02% | 394 |
|
|
2025
Q2 | $7.87M | Sell |
17,683
-681
| -4% | -$314K | 0.03% | 332 |
|
|
2025
Q1 | $8.9M | Sell |
18,364
-162
| -0.9% | -$75.5K | 0.03% | 306 |
|
|
2024
Q4 | $7.46M | Sell |
18,526
-341
| -2% | -$158K | 0.03% | 346 |
|
|
2024
Q3 | $8.77M | Sell |
18,867
-1,074
| -5% | -$516K | 0.03% | 326 |
|
|
2024
Q2 | $9.35M | Sell |
19,941
-2,075
| -9% | -$901K | 0.03% | 313 |
|
|
2024
Q1 | $9.2M | Sell |
22,016
-24,909
| -53% | -$10.5M | 0.03% | 319 |
|
|
2023
Q4 | $19.1M | Sell |
46,925
-4,824
| -9% | -$1.78M | 0.07% | 214 |
|
|
2023
Q3 | $18M | Sell |
51,749
-2,451
| -5% | -$857K | 0.07% | 220 |
|
|
2023
Q2 | $19.1M | Buy |
54,200
+1,511
| +3% | +$509K | 0.07% | 225 |
|
|
2023
Q1 | $16.6M | Buy |
52,689
+35,703
| +210% | +$10.7M | 0.06% | 243 |
|
|
2022
Q4 | $4.9M | Buy |
16,986
+1,201
| +8% | +$366K | 0.02% | 416 |
|
|
2022
Q3 | $4.57M | Buy |
15,785
+1,802
| +13% | +$518K | 0.02% | 405 |
|
|
2022
Q2 | $3.71M | Buy |
13,983
+2,939
| +27% | +$787K | 0.02% | 420 |
|
|
2022
Q1 | $2.88M | Buy |
11,044
+1,901
| +21% | +$451K | 0.01% | 466 |
|
|
2021
Q4 | $2.01M | Buy |
9,143
+65
| +0.7% | +$12.6K | 0.01% | 564 |
|
|
2021
Q3 | $1.65M | Sell |
9,078
-11,405
| -56% | -$2.23M | 0.01% | 610 |
|
|
2021
Q2 | $4.13M | Sell |
20,483
-665
| -3% | -$139K | 0.02% | 419 |
|
|
2021
Q1 | $4.54M | Sell |
21,148
-4,884
| -19% | -$1.07M | 0.02% | 395 |
|
|
2020
Q4 | $6.15M | Sell |
26,032
-3,403
| -12% | -$781K | 0.03% | 333 |
|
|
2020
Q3 | $8.01M | Buy |
29,435
+1,630
| +6% | +$450K | 0.04% | 272 |
|
|
2020
Q2 | $8.07M | Buy |
27,805
+3,347
| +14% | +$907K | 0.04% | 264 |
|
|
2020
Q1 | $5.82M | Buy |
24,458
+1,175
| +5% | +$270K | 0.03% | 313 |
|
|
2019
Q4 | $5.1M | Buy |
23,283
+2,500
| +12% | +$506K | 0.02% | 278 |
|
|
2019
Q3 | $3.52M | Sell |
20,783
-4,910
| -19% | -$869K | 0.02% | 397 |
|
|
2019
Q2 | $4.71M | Buy |
25,693
+792
| +3% | +$138K | 0.02% | 341 |
|
|
2019
Q1 | $4.58M | Sell |
24,901
-427
| -2% | -$78.9K | 0.02% | 337 |
|
|
2018
Q4 | $4.2M | Buy |
25,328
+3,619
| +17% | +$627K | 0.02% | 337 |
|
|
2018
Q3 | $4.18M | Buy |
21,709
+850
| +4% | +$151K | 0.02% | 380 |
|
|
2018
Q2 | $3.54M | Buy |
20,859
+596
| +3% | +$92.4K | 0.02% | 403 |
|
|
2018
Q1 | $3.3M | Sell |
20,263
-886
| -4% | -$145K | 0.02% | 426 |
|
|
2017
Q4 | $3.17M | Buy |
21,149
+1,639
| +8% | +$243K | 0.02% | 435 |
|
|
2017
Q3 | $2.97M | Buy |
19,510
+3,748
| +24% | +$564K | 0.02% | 452 |
|
|
2017
Q2 | $2.03M | Sell |
15,762
-564
| -3% | -$67.9K | 0.01% | 531 |
|
|
2017
Q1 | $1.78M | Sell |
16,326
-622
| -4% | -$54.8K | 0.01% | 568 |
|
|
2016
Q4 | $1.25M | Buy |
16,948
+1,711
| +11% | +$139K | 0.01% | 690 |
|
|
2016
Q3 | $1.33M | Sell |
15,237
-176
| -1% | -$16.6K | 0.01% | 675 |
|
|
2016
Q2 | $1.32M | Sell |
15,413
-1,041
| -6% | -$89.9K | 0.01% | 677 |
|
|
2016
Q1 | $1.31M | Sell |
16,454
-5,978
| -27% | -$541K | 0.01% | 684 |
|
|
2015
Q4 | $2.82M | Sell |
22,432
-1,336
| -6% | -$161K | 0.02% | 455 |
|
|
2015
Q3 | $2.47M | Sell |
23,768
-18,677
| -44% | -$2.4M | 0.02% | 500 |
|
|
2015
Q2 | $5.24M | Sell |
42,445
-19,406
| -31% | -$2.45M | 0.03% | 340 |
|
|
2015
Q1 | $7.3M | Sell |
61,851
-517
| -0.8% | -$61.9K | 0.05% | 293 |
|
|
2014
Q4 | $7.41M | Buy |
62,368
+8,060
| +15% | +$908K | 0.05% | 292 |
|
|
2014
Q3 | $6.1M | Buy |
54,308
+54,208
| +54,208% | +$5.16M | 0.04% | 325 |
|
|
2014
Q2 | $9K | Sell |
100
-178
| -64% | -$12.5K | ﹤0.01% | 948 |
|
|
2014
Q1 | $19K | Sell |
278
-408
| -59% | -$32.3K | ﹤0.01% | 861 |
|
|
2013
Q4 | $51K | Sell |
686
-956
| -58% | -$66.6K | ﹤0.01% | 676 |
|
|
2013
Q3 | $125K | Sell |
1,642
-1,508
| -48% | -$120K | 0.01% | 468 |
|
|
2013
Q2 | $252K | Buy |
+3,150
| New | +$232K | 0.01% | 380 |
|
Other funds holding VRTX
VCM
VPM
M&T Bank's VRTX Position: Q1 2026 in Review
M&T Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 11% in Q1 2026, selling an estimated $767K and leaving 13,088 shares worth $5.84M. The position accounts for 0.02% of the portfolio, ranked #359.
M&T Bank first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.1M in Q4 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- M&T Bank held 13,088 shares of Vertex Pharmaceuticals worth $5.84M as of Q1 2026.
- M&T Bank sold 1,644 Vertex Pharmaceuticals shares in Q1 2026, an estimated $767K.
- Vertex Pharmaceuticals made up 0.02% of M&T Bank's portfolio in Q1 2026, its #359 holding.
- M&T Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- M&T Bank's Vertex Pharmaceuticals position peaked at $19.1M in Q4 2023.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.